Skip to main content
Kate Barker on Muck Rack

Kate Barker

As seen in: The Guardian, The Telegraph, SAGE Publishing, Yahoo Sports Canada, LSE Connect, The Drum, Duolingo, Times Higher Education, Spiked, CustomerThink and
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Kate

Contact Kate, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

文化によって大きく違う⁠！世⁠界の名字や名前の付け方の習⁠慣

|
By Kate Barker
| Duolingo
なぜ僕の名前はアフメドになったんだろう？ これは、Radiolingoの第1話「What’s in a Name?」の冒頭の一文です。このエピソードでは、ホストのアフメド・アリ・アクバルが、移民二世がどのように名前を選んでいるのか、そしてその選択がどんな影響を持つのかを探っています。両親の出身国によって名前の付け方の伝統は異なり、それぞれのコミュニティとその文化の価値観が大きく反映されます。実際、名前は、その持ち主についても、そしてその名前を選んだ人についても、興味深い洞察を与えてくれるのです。 私がケイトとなった理由 西洋の命名の伝統について少しでも知っている方は、私の名前「ケイト・バーカー」から、私についての情報をある程度推察できることでしょう。たとえば、私は女性で、父の姓はおそらくバーカー、そして私のファーストネームは、おそらく本名を短縮した愛称だろう、ということなどです。とは言っても、なぜこの名前を選んだかについては、まあ、たぶん両親にとって響きが気に入ったからにすぎないと思いますが...
Open in Who Shared Issue with article?

The economic costs of British planning: unaffordable housing and lost employment and productivity

|
By Kate Barker, Stephen Aldridge
| LSE Connect Verified
This event brings together some of the key contributors to this long running debate and underline LSE’s commitment to engage in this important public policy issue. This event brings together some of the key contributors to this long running debate and underline LSE’s commitment to engage in this important public policy issue.
Open in Who Shared Issue with article?

The puberty-blockers trial will ‘trans away the gay’ Original

|
By Kate Barker
| Spiked Verified
Wes Streeting must put a stop to the NHS’s plan to medicalise homosexuality. Share Topics Identity Politics Politics UK Want unlimited, ad-free access? Become a spiked supporter. Starting next month, the NHS will perform a medical experiment on more than 200 physically healthy children. Under the new Pathways Trial, these children will receive a regular dose of a drug, GnRHa, which will prevent them from going through puberty.
Open in Who Shared View Duplicates (2) Issue with article?
See all 42 licensed articles (51 Total)